Abstract: A controller collectively transmits game view data of a game having a set of a plurality of rounds to a user terminal. The game view data corresponds to a first subset of rounds including a predetermined number of rounds in the plurality of rounds. The controller collectively transmits game view data corresponding to a second subset of rounds to the user terminal responsive to detecting that the first subset of the rounds is completed. The second subset of rounds includes the predetermined number of rounds subsequent to the completed rounds.

Abstract: A controller collectively transmits game view data of a game having a set of a plurality of rounds to a user terminal. The game view data corresponds to a first subset of rounds including a predetermined number of rounds in the plurality of rounds. The controller collectively transmits game view data corresponding to a second subset of rounds to the user terminal responsive to detecting that the first subset of the rounds is completed. The second subset of rounds includes the predetermined number of rounds subsequent to the completed rounds.

Abstract: The present invention relates to sustained-release pharmaceutical compositions for ionic pharmaceutically active substances containing ionic compounds having opposite charges to those of ionic prostanoic acid derivatives and increasing hydrophobicity of the active substances. More specifically, the invention relates to sustained-release pharmaceutical compositions comprising the ionic prostanoic acid derivatives and the ionic compounds having opposite charges to those of the prostanoic acid derivatives and increasing hydrophobicity of these derivatives that contain hydrophobic groups in the molecule thereof. The pharmaceutical composition of the invention can exhibit excellent sustained release effect of the ionic prostanoic acid derivatives, irrespective of water solubility possessed by the ionic prostanoic acid derivatives.

Abstract: A sustained release preparation of prostaglandin I derivatives, which is highly safe and has stable drug-releasing and absorption properties, is disclosed. In the orally administrable preparation, the active component is a prostaglandin I derivative and the release-controlling component is a hydrogel base.

Abstract: An agent for enhancing accumulation of drugs in tumor tissues, which can enhance accumulation of the drugs in tumor tissues, which drugs are used for diagnosis or therapy of tumors, is disclosed. The agent for enhancing accumulation of drugs in tumor tissues according to the invention comprises as an effective ingredient a prostaglandin I derivative such as beraprost or a salt thereof.

Abstract: An agent for enhancing accumulation of drugs in tumor tissues, which can enhance accumulation of the drugs in tumor tissues, which drugs are used for diagnosis or therapy of tumors, is disclosed. The agent for enhancing accumulation of drugs in tumor tissues according to the invention comprises as an effective ingredient a prostaglandin I derivative such as beraprost or a salt thereof.

Abstract: A stable pharmaceutical composition includes a 4,5-epoxy-morphinan derivative, and includes at least one of the group consisting of a water soluble antioxidant, a fat soluble antioxidant, a synergist, a sugar, and a surfactant.

Abstract: A stable pharmaceutical composition includes a 4,5-epoxy-morphinan derivative, and includes at least one of the group consisting of a water soluble antioxidant, a fat soluble antioxidant, a synergist, a sugar, and a surfactant.

Abstract: The present invention provides a preparation for percutaneous absorption comprising as an effective component a prostaglandin I.sub.2 derivative and a fatty acid or a derivative thereof, or a mixture of two or more of these, which has high percutaneous permeability of the PGI.sub.2 derivative. Particularly, the present invention provides a preparation for percutaneous absorption comprising 5,6,7-trinor-4,8-inter-m-phenylene PGI.sub.2 derivative and a C.sub.6 -C.sub.24 fatty acid, a salt thereof or an ester thereof, or a mixture of two or more of these, which has high percutaneous permeability of the PGI.sub.2 derivative. This preparation for percutaneous absorption suggests a possibility to last pharmacological effects and to reduce side effects. Thus, the preparation is expected to be used for therapy of various diseases, aiming at topical and systemic actions.

Abstract: A system of adding an operand address included in an instruction word to the contents of a modification register to obtain an effective address, wherein address data which designates each of a plurality of data tables constituted with prescribed storage capacity, is stored in a plurality of modification registers. Prescribed address data of one of the plurality of modification registers is selected based on the instruction word. The effective address for addressing the operand is obtained by adding the prescribed address data of the one of the plurality of modification registers to address data included in the operand address. The address data included in the operand address designates addresses which correspond to addresses of the plurality of data tables.

Abstract: A telephone transmission circuit for connection to telephone line terminals includes a transmitter amplifier, a receiver amplifier and a balancing circuit for suppressing the leakage of the output of the transmitter amplifier to the receiver amplifier, the transmitter amplifier being connected to the line terminals so that a power supplied from the line is effectively used. Good impedance matching between the line and the telephone transmission circuit is achieved by the automatic adjustment of the balancing circuit responsive to the line length between the telephone transmission circuit and an exchange.

Abstract: An analog-to-digital converter comprising a capacitive element for storing an analog input signal, a discharge means for discharging the charge stored in said capacitive element, a means for counting the number of clockpulses between the time of discharge starting and the time at which the voltage at the output of said capacitive element reaches a certain detection level, and a bias voltage supply means for supplying a bias voltage in order to bring the voltage at the output terminal of said capacitive element at the discharge starting time above said detection level.

Abstract: An analog-to-digital converter comprising a capacitor for storing an analog input signal, a constant current discharging circuit coupled with the capacitor for discharging the charge stored therein, a level detection circuit connected to the input terminal of the capacitor, a counter connected to the output terminal of the level detection circuit for counting the number of clock-pulses between the time of discharge start and the time when the voltage at the input terminal of the capacitor drops to a detection level of the level detection circuit, a bias voltage supply means connected in series with the capacitor for adding a bias voltage to the voltage at the input terminal of said capacitor, and a switch connected in parallel with the capacitor for short-circuiting the capacitor when the voltage at the input terminal of said capacitor drops to the detection level.

Abstract: An arrangement for indicating a relative azimuth between two objects remote from each other, such as a control station and a mobile unit remotely controlled by the station, on which are respectively mounted first and second synchronous transmitters for generating and transmitting their respective signals corresponding respectively to true azimuths of the station and the unit. The control station is further provided with a relative azimuth indicating device including outer stational and inner rotatable dials, a rotatable indicator, first and second synchronous receivers, each having means for effecting rotation by receiving one of the signals corresponding thereto, and means for transmitting the respective rotations of the receivers to the inner dial and the indicator, respectively.